Researchers say if their results are confirmed through further study they are optimistic the approach could be used to treat chronic infections for the first time.

New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center ...

This study provides evidence that single-cell multi-omics profiling can reveal key regulators of HIV-1 persistence and early immune dysregulation, particularly implicating KLF2 and Th17 cells as major ...

Researchers at The Wistar Institute's HIV Cure and Viral Diseases Center have successfully identified a new approach using ...

A new study says the flu A viral strain can adapt shape to stay infectious. Infectious disease doctors break down what this means and how to protect yourself.

WOBURN, Mass., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today ...

MSD began worldwide recruitment for the trial and subjects are currently being enrolled. In the randomised trial, the ...

This study evaluates the role of the late viral protein, pA104R, in African swine fever virus immunosuppression ... genes were attenuated by pA104R treatment in HEK-293 T cells. Immunoprecipitation ...

1 and 6B.2 lineages on Madin-Darby canine kidney (MDCK) and human lung adenocarcinoma epithelial (A549) cells and their pathogenicity and transmission in guinea pigs were also compared. Results: In ...